Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 15.7T | 15.6T | 16.3T | 14.7T |
| Cost of revenue | 4.2T | 4.2T | 4.2T | 3.9T |
| Gross profit | 11.5T | 11.5T | 12.0T | 10.8T |
| Operating expense | ||||
| Research & development | 2.8T | 2.9T | 2.9T | 2.7T |
| Selling general and admin | 4.4T | 4.5T | 5.0T | 4.3T |
| Other operating expenses | 19.1B | 13.9B | 93.7B | 38.2B |
| Operating income | 4.3T | 4.0T | 4.1T | 3.8T |
| Non operating interest income | ||||
| Income | 549.8B | 702.4B | 1.0T | 416.2B |
| Expense | 464.8B | 485.6B | 529.0B | 418.0B |
| Other income expense | -36.4B | 17.3B | -704.1B | -17.3B |
| Pretax income | 4.3T | 4.3T | 3.8T | 3.7T |
| Tax provision | 1.3T | 1.2T | 1.0T | 1.2T |
| Net income | 3.0T | 3.1T | 2.8T | 2.5T |
| Basic EPS | 4.4 | 4.6 | 4.1 | 3.8 |
| Diluted EPS | 4.3 | 4.5 | 4.1 | 3.7 |
| Basic average shares | 674.1B | 674.6B | 673.5B | 674.1B |
| Diluted average shares | 679.3B | 680.4B | 679.8B | 675.2B |
| EBITDA | 5.4T | 5.4T | 6.0T | 4.6T |
| Net income from continuing op. | 3.0T | 3.1T | 2.8T | 2.5T |
| Minority interests | -90.2B | -27.7B | -26.0B | 39.9B |
| Preferred stock dividends | — | — | — | — |